Kerbside

Sagar Bhosale

The recommendations provided in this column are taken from various market sources such as brokers, analysts, dealers and investment strategists, etc. These recommendations may not be backed by strong fundamentals. Therefore we advise readers to use their own discretion before investing in these recommendation 


DOMINANCE IN ANTI-MALARIAL BUSINESS


Ipca Laboratories 
BSE Code: 524494 
CMP: Rs 635 


Ipca Laboratories is known for its dominance in the anti-malarial business. It has come a long way from being an anti-malarial player to a player offering a range of other therapeutic products. The company posted robust Q3 results, with revenues growing 14 per cent YoY on the back of 12% growth in domestic formulations and 17 per cent growth in export formulations. The PAT jumped 140 per cent YoY to Rs 106 crore due to strong operational performance and lower tax rate. The management has guided EBITDA margins at 18-18.5 per cent in FY19. On the Institutional exports segment, the management expects the WHO anti-malarial tender to kick-start from Q1FY19. The stock could deliver good returns from the current level. 


INDUSTRIAL LEADER 


Precision Wire 
BSE Code: 523539 
CMP: Rs 321 


The company produces winding wires made of copper which are used in the manufacture of both rotating and static electric equipments. Though there are number of players in the industry, the company remains industry leader due to the quality of its products and longstanding relationship with OEMs. The company has reported formidable performance in quarter ended December 2017 and, as per our market sources, HNIs are closely monitoring this stock. Hence, investors with high risk appetite can invest in this stock for handsome gains. 


BUY RATING 
Larsen & Toubro 
BSE Code: 500510 
CMP: Rs 1351


Despite the stellar performance of the stock in the last 8-10 months, the engineering major remains one of the top picks in the industrial play. The company has ticked all the right boxes in Q3. Post the Q3 results, majority of the broking and research houses had revised the rating of this stock. Now, with good correction from the higher levels, this stock looks an attractive buy at the current levels.  






AND FINALLY.. 

Gujarat Ambuja Exports 
BSE Code: 524226 
CMP: Rs 255 

Gujarat Ambuja Exports is India’s leading manufacturer of agro-processed products and cotton yarn. The company has three business segments, namely, agro processing, corn/maize processing and cotton yarn. While in revenue terms, the contribution of the agro-processing division is prominent, the maize segment has become the company’s core and key focus area due to higher and stable margins and better growth prospects. The standalone net profit of the company reported about 39 per cent jump at Rs 63.30 in Q3. The stock has the potential for an upmove in the short term.

Rate this article:
No rating
Comments are only visible to subscribers.

Equity Research

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR